Pawlak Agnieszka, Gewartowska Magdalena, Przybylski Maciej, Kuffner Mateusz, Wiligórska Diana, Gil Robert, Król Zbigniew, Frontczak-Baniewicz Malgorzata
Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior and Administration in Warsaw, 02-507 Warsaw, Poland.
Department of Applied Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.
J Pers Med. 2022 Jan 28;12(2):177. doi: 10.3390/jpm12020177.
Understanding the meaning of parvovirus B19 (PB19V) in an etiology of dilated cardiomyopathy (DCM) is difficult. Viruses change the dynamics of the mitochondria by interfering with the mitochondrial process/function, causing the alteration of mitochondrial morphology. In this study, the ultrastructural changes in the mitochondria in endomyocardial biopsy (EMB) samples from patients with DCM and PB19V were determined.
The PB19V evaluation was performed in EMB specimens by real-time PCR in 20 patients (age: 28 ± 6 years). The biopsy specimens were examined by histo- and immunohistochemistry to detect the inflammatory response. The ultrastructural features of the mitochondria were evaluated by electron microscopy.
The presence of PB19V in the heart tissue without the presence of inflammatory process, defined according to Dallas and immunohistochemical criteria, was associated with ultrastructural changes in the mitochondria. Distinctive ultrastructural pathologies were indicated, such as the presence of mitochondria in the vicinity of the expanded sarcoplasmic reticulum with amorphous material, blurred structure of mitochondria, interrupted outer mitochondrial membrane and mitophagy.
Extending diagnostics with ultrastructural analysis of biopsy samples provides new knowledge of the changes associated with the presence of PB19V in the heart tissue. The observed changes can be a basis for searching for the damage mechanisms, as well as for new therapeutic solutions.
了解细小病毒B19(PB19V)在扩张型心肌病(DCM)病因中的意义颇具难度。病毒通过干扰线粒体过程/功能来改变线粒体的动态变化,从而导致线粒体形态改变。在本研究中,确定了DCM合并PB19V患者心内膜心肌活检(EMB)样本中线粒体的超微结构变化。
对20例患者(年龄:28±6岁)的EMB标本进行实时PCR检测PB19V。通过组织学和免疫组织化学检查活检标本以检测炎症反应。通过电子显微镜评估线粒体的超微结构特征。
根据达拉斯标准和免疫组织化学标准,在无炎症过程的心脏组织中存在PB19V与线粒体超微结构变化相关。显示出独特的超微结构病变,如在扩张的肌浆网附近存在线粒体并伴有无定形物质、线粒体结构模糊、线粒体外膜中断和线粒体自噬。
通过对活检样本进行超微结构分析来扩展诊断,可为心脏组织中PB19V存在相关的变化提供新知识。观察到的这些变化可作为探寻损伤机制以及新治疗方案的基础。